SOTs: solid organ tumors; HMs: hematological malignancies; SM: secondary malignancy; FCR: fludarabine, cyclophosphamide, rituximab; BTKi: Bruton’s tyrosine kinase inhibitor. The gene discussed is IBTK; the disease is hematologic disorder.